|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Dicerna Pharmaceuticals (NASDAQ: DRNA) through any online brokerage.
The latest price target for Dicerna Pharmaceuticals (NASDAQ: DRNA) was reported by HC Wainwright & Co. on June 23, 2021. The analyst firm set a price target for 42.00 expecting DRNA to rise to within 12 months (a possible 9.72% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Dicerna Pharmaceuticals (NASDAQ: DRNA) is $38.28 last updated Thu Jun 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Dicerna Pharmaceuticals.
There is no upcoming split for Dicerna Pharmaceuticals.
Dicerna Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.